AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS - 2023 Issue 1; Section X - New Technology

Introduction of New Therapeutic Substances

In Section X, New Technology, table XW0, Introduction of Anatomical Regions, value G REGN-COV2 Monoclonal Antibody, was added to body part 1 Subcutaneous Tissue, to identify the administration of the combination of 2 monoclonal antibodies, carsirivimab and imdevimab to treat COVID-19.Body Part Approach Device/ Substance/ Technology Qualifier 1 Subcutaneous Tissue 3 Percutaneous G REGN-COV2 Monoclonal Antibody 6 New Technology Group 6 The Substance K Sabizabulin was added to table XW0, Introduction of Anatomical Regions, at body parts D Mouth and Pharynx, G Upper GI and H Lower GI to capture administration of sabizabulin, an antiviral/anti-inflammatory therapeutic that may...

To read the full article, sign in and subscribe to AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS .


  • The official AHA publication for ICD-10-CM and ICD-10-PCS coding guidelines and advice
  • Current newsletters added each quarter
  • Full Archives - over 3100 articles
  • ALL years/issues back to 1984 organized by year and issue
  • Includes ICD-10-CM/PCS Articles since 2013
  • Fully searchable through Find-A-Code's Comprehensive Search
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information pages link back to related articles
  • View all the articles associated with any code, right from the code page!
Access to this feature is available in the following products:
  • AHA's Coding Clinic® - ICD-10-CM/PCS +Archives

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.